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Mitose como fator prognóstico para biópsia de linfonodo sentinela em
melanoma fino
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Abstract: 23-year-old female patient, with superficial spreading melanoma (SSM) on the back, Breslow
0.35 mm, Clark II, without ulceration and with 2 mitosis/mm2. Patient was submitted to margin enlarge-
ment and sentinel biopsy of 2 lymph nodes (left armpit). Histopathology revealed micrometastasis in the
subcapsular sinus of both. Following the recommendation of the 2009 American Joint Committee on
Cancer Melanoma Staging (AJCC), the patient underwent complete axillary lymphadenectomy. No other
lymph nodes were metastatic. The clinical application of dermoscopy has enabled more accurate diagno-
sis of cutaneous melanoma, probably contributing to a greater proportion of thin melanomas at diagno-
sis. The mitotic rate was included as an important prognostic factor for thin melanomas by the AJCC, sug-
gesting biopsy for these patients.
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Resumo: Paciente, sexo feminino, 23 anos, com melanoma extensivo superficial em dorso, Breslow 0,35
mm, Clark II, sem ulcerações e com 2 mitoses / mm2. Foi submetida à ampliação de margem e biópsia de
dois linfonodos sentinela (axila esquerda). O exame anatomopatológico mostrou micrometástases, no seio
subcapsular de ambos. Seguindo a recomendação do "American Joint Commitee on Cancer" 2009, a
paciente foi submetida à linfadenectomia axilar total, sem outros linfonodos metastáticos. A aplicação da
dermatoscopia vem permitindo maior precisão diagnóstica de melanoma cutâneo, contribuindo para maior
proporção de melanoma fino ao diagnóstico. A taxa mitótica foi incluída como um importante fator
prognóstico para melanomas finos pelo "American Joint Commitee on Cancer" 2009, sugerindo biópsia
para esses pacientes.
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CASE REPORT
INTRODUCTION
The incidence of melanoma is increasing world-
wide and the proportion of thin melanoma (Breslow
thickness ≤ 1 mm) at diagnosis is
significant. 1,2 Sentinel lymph node biopsy has proved
to be an accurate approach for regional lymph node
staging with minimal morbidity, and has been adopt-
ed by the 2009 American Joint Committee on Cancer
Melanoma Staging (AJCCMS). The lymph node status
is the most important prognostic factor for
melanoma. 3,4 The sentinel lymph node biopsy was
developed to identify the 20% of patients with primary
intermediate thickness melanoma (0.76mm - 4 mm)
who have lymph node metastases. 3 It is known that a
small proportion (less than 10%) of melanoma
patients with thin melanoma at diagnosis, develop
lymph node metastases. 1,5,6,7 Given the increasing
number of patients with thin melanoma diagnosis,
there is substantial interest in detecting high risk
prognostic factors for lymph node metastases. It fol-
lows that it will be of great interest to select a sub-
group in which sentinel lymph node biopsy may be
helpful. According to the 2009 AJCCMS, the presence
of mitosis greater than or equal to 1/mm2 in the pri-
mary tumor T1 classifies melanomas as T1b. These
patients should undergo sentinel node biopsy. In a
recent meta-analysis, three studies analyzed
melanomas with a mitotic rate greater than or equal
to 1/mm2. In this study 588 cases were analyzed, of
which 350 cases had a mitotic rate of ≥ 1/ mm2. Of the
latter, 24 had a positive sentinel lymph node. 238
cases revealed no mitoses and five had a positive sen-
tinel lymph node (OR: 2.91, CI: 95% [1.12 to 7.55];
68% I2). 1,8,9 The present clinical case report draws
attention to the importance of mitotic rate as a prog-
nostic factor for patients with melanoma.
CASE REPORT
23-year-old female patient presented with
superficial spreading melanoma on the back at the
radial growth phase, Breslow 0.35 mm, Clark II, no
ulcerations, no regression areas and 2
mitoses/mm 2 (Figure 1). The anatopathological exam-
ination revealed moderate intratumoral and peritu-
moral lymphocytic infiltration, without angiolymphat-
ic or perineural invasion or satellitosis and with
tumor-free surgical margins (Figure
2). Immunohistochemistry of the primary tumor was
not done. Physical examination revealed several dys-
plastic nevi on the trunk and a scar on the back where
an excisional biopsy of the melanoma had been
made. The patient´s mother had had melanoma. The
patient was being monitored (with regular der-
moscopy) by a dermatologist in view of the presence
of multiple dysplastic nevi. Patient was asymptomatic.
Given that abdominal ultrasound, chest radiography
and serum LDH were normal, she was classified as
pT1bNxMo. The patient was submitted to amplifica-
tion of the margins and sentinel node biopsy. The pre-
operative lymphoscintigraphy showed two lymph
nodes in the left axillary region, both of which were
removed. Although the conventional anatopathologi-
cal examination with HE showed no presence of can-
cer, the immunohistochemical survey however
revealed micrometastases in both sentinel lymph
nodes for  antigens Melan A and S100 Protein. The
micrometastases were found within the subcortical
sinus, measuring 1.0 mm and 0.2 mm in the lymph
nodes (Figure 3). The patient then underwent total
axillary dissection, with no involvement of any other
node among the 18 removed. PET-SCAN was normal
and the patient is now on interferon immunotherapy.
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FIGURE 1: Nest of melanocytic cells and asymmetrical lymphocytic
infiltrate
FIGURE 2: Invasion of melanocytic cells with lymphocytic infiltrate
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DISCUSSION 
The incidence of melanoma is increasing
worldwide. 2,10 Thin melanomas represent a significant
proportion of new cases of melanoma. The clinical
application of dermoscopy has enabled greater diag-
nostic accuracy for cutaneous melanoma, probably
contributing to a greater proportion of thin
melanomas detected at diagnosis. Although it has not
yet been definitively established which patients
should undergo sentinel lymph node biopsy, the 2009
American Joint Commitee on Cancer  Melanoma
Staging includes mitosis as an important prognostic
risk factor for thin melanomas, suggesting sentinel
node biopsy for patients in this condition. 11,12 Positive
biopsy moves these patients up to stage III. Published
data suggest that a biopsy combined with immediate
lymphadenectomy may improve overall disease-free
survival rates. 13 Mitosis in primary melanoma identi-
fies patients with a high risk of recurrence, as can be
clearly observed in the case described above. ❑
FIGURE 3: Micrometastasis in subcortical sinus of sentinel 
lymph node 
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